Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis

Vikas Gupta, Sue Richards, Jacob Rowe

Blood (2013) 121 (2): 339–350.

https://doi.org/10.1182/blood-2012-07-445098

Published: 2013

Includes: Supplemental data

Journal Articles

WT1 mutations in T-ALL

Blood (2009) 114 (5): 1038–1045.

https://doi.org/10.1182/blood-2008-12-192039

Published: 2009

Includes: Supplemental data

Journal Articles

Fusion Cell Vaccination in Conjunction with Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and Is Associated with Responses in Patients with Multiple Myeloma

Blood (2008) 112 (11): 826.

https://doi.org/10.1182/blood.V112.11.826.826

Published: 2008

Journal Articles

HLA-Identical Allogeneic Stem Cell Transplantation (alloSCT) for Patients with Primary Cutaneous T-Cell Lymphoma (CTCL): A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT-LWP).

Rafael Duarte, Carme Canals, Francesco Onida, Eduardo Olavarria, William Arcese, Augustin Ferrant, Franco Narni, Andrea Bacigalupo, Donald Bunjes, Jacob Rowe, Giorgio Lambertenghi, Norbert Schmitz, Anna Sureda

Blood (2008) 112 (11): 1132.

https://doi.org/10.1182/blood.V112.11.1132.1132

Published: 2008

Journal Articles

Induced CD4 + CD25 + FOXP-3 + and CD8+CD25 + FOXP-3 + t Cells Exhibit a Concurrent Expression of Effector and Selective Suppressive Capacities

Irit Avivi, MD, Dina Stroopinsky, Jacob Rowe, MD, David Avigan, MD, Tami Katz, Ph.D

Blood (2008) 112 (11): 3501.

https://doi.org/10.1182/blood.V112.11.3501.3501

Published: 2008

Journal Articles

A 3,239 -Patient Combined Eastern Cooperative Oncology Group (ECOG), M.D. Anderson Cancer Center (MDA) Analysis of the Effect of CR vs. Responses < CR on Long-Term Survival in Newly-Diagnosed AML Treated with Ara-C-Containing Regimens: Implications for Targeted Drug Development.

Elihu Estey, MD, Zhuoxin Sun, MD, Jacob Rowe, MD, Stefan Faderl, MD, Peter Cassileth, MD, George Sartiano, MD, Anthony Tartaglia, MD, Guillermo Garcia-Manero, MD, Larry Cripe, MD, John Bennett, MD, Hagop Kantarjian, MD, Martin Tallman, MD

Blood (2007) 110 (11): 298.

https://doi.org/10.1182/blood.V110.11.298.298

Published: 2007

Journal Articles

Phase III Trial of All-Trans Retinoic Acid (ATRA) vs Daunorubicin (D) and Cytosine Arabinoside (A) as Induction Therapy and ATRA vs Observation as Maintenance Therapy for Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL).

John Gregory, MD, Haesook Kim, PhD, Todd Alonzo, MD, Rob Gerbing, PhD, Angela Ogden, MD, William Woods, MD, Howard Weinstein, MD, Lois Shepherd, MD, Charles Schiffer, MD, Frederick Appelbaum, MD, Cheryl Willman, MD, Peter Wiernik, MD, Jacob Rowe, MD, Martin Tallman, MD, James Feusner, MD

Blood (2005) 106 (11): 894.

https://doi.org/10.1182/blood.V106.11.894.894

Published: 2005

Journal Articles

Phase III Prospective Randomized Trial of EPO with or without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes (MDS): Results of the ECOG- CLSG Trial(E1996).

Kenneth B. Miller, MD, Haesook T. Kim, PhD, Peter Greenberg, MD, Richard van der Jagt, MD, John M. Bennett, MD, Martin S. Tallman, MD, Elisabeth Paietta, PhD, Gordon Dewald, PhD, Jessie G. Houston, MD, Mary Thomas, RN, MS, Jacob Rowe, MD

Blood (2004) 104 (11): 70.

https://doi.org/10.1182/blood.V104.11.70.70

Published: 2004

Journal Articles

The Outcome of 551 1 st CR Transplants in Adult ALL from the UKALL XII/ECOG 2993 Study.

Anthony H. Goldstone, Hillard J. Lazarus, Sue M. Richards, Mark R. Litzow, Raj Chopra, Alan Burnett, Peter H. Wiernik, Ian M. Franklin, H. G. Prentice, Martin Tallman, G. Harrison, Jill Durrant, Jacob Rowe

Blood (2004) 104 (11): 615.

https://doi.org/10.1182/blood.V104.11.615.615

Published: 2004

Journal Articles

Impact of Cytogenetics on Outcome of Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Adults with AML.

Martin Tallman, Gordon Dewald, Hillard Lazarus, Sharavi Gandham, Gene Nelson, Brent Logan, Jacob Rowe, Mark Litzow, Armand Keating, Jayesh Mehta, Meir Wetzler, Tanya Warren, Daniel Weisdorf

Blood (2004) 104 (11): 830.

https://doi.org/10.1182/blood.V104.11.830.830

Published: 2004

Journal Articles

Improved Leukemia-Free Survival after Post-Consolidation Treatment with Histamine Dihydrochloride and Interleukin-2 in AML: A Randomized Phase III Trial.

Mats Brune, MD, Sylvie Castaigne, MD, John Catalano, MD, Kurt Gehlsen, PhD, Wolf-Karsten Hofmann, MD, Anthony Ho, MD, Donna Hogge, MD, Bo Nilsson, MD, Reuven Or, MD, Jacob Rowe, MD, Bengt Simonsson, MD, Ruth Spearing, MD, Edward Stadtmauer, MD, Jeff Szer, MD, Elisabeth Wallhult, RN, Kristoffer Hellstrand, MD

Blood (2004) 104 (11): 261.

https://doi.org/10.1182/blood.V104.11.261.261

Published: 2004

NARROW

Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis

WT1 mutations in T-ALL

Fusion Cell Vaccination in Conjunction with Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and Is Associated with Responses in Patients with Multiple Myeloma

HLA-Identical Allogeneic Stem Cell Transplantation (alloSCT) for Patients with Primary Cutaneous T-Cell Lymphoma (CTCL): A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT-LWP).

Induced CD4 + CD25 + FOXP-3 + and CD8+CD25 + FOXP-3 + t Cells Exhibit a Concurrent Expression of Effector and Selective Suppressive Capacities

A 3,239 -Patient Combined Eastern Cooperative Oncology Group (ECOG), M.D. Anderson Cancer Center (MDA) Analysis of the Effect of CR vs. Responses < CR on Long-Term Survival in Newly-Diagnosed AML Treated with Ara-C-Containing Regimens: Implications for Targeted Drug Development.

Phase III Trial of All-Trans Retinoic Acid (ATRA) vs Daunorubicin (D) and Cytosine Arabinoside (A) as Induction Therapy and ATRA vs Observation as Maintenance Therapy for Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL).

Phase III Prospective Randomized Trial of EPO with or without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes (MDS): Results of the ECOG- CLSG Trial(E1996).

The Outcome of 551 1 st CR Transplants in Adult ALL from the UKALL XII/ECOG 2993 Study.

Impact of Cytogenetics on Outcome of Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Adults with AML.

Improved Leukemia-Free Survival after Post-Consolidation Treatment with Histamine Dihydrochloride and Interleukin-2 in AML: A Randomized Phase III Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only